Related Posts
On February 21, 2025, the...
In a major development, a...
Tukysa is a kinase inhibitor recommended...
Relapsing multiple sclerosis (MS) is...
Understanding Cytomegalovirus (CMV) Infection and...
Recent Posts
- Takeda’s Qdenga Vaccine: A Breakthrough in Dengue Prevention Coming to India
- New Acute Myeloid Leukemia (AML) Treatments
- Indian Company Can Manufacture Risdiplam for Spinal Muscular Atrophy (SMA)
- X-Linked Hypophosphatemia: Symptoms, Diagnosis, & Treatment
- FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors